DEA and SAMHSA Extend Telemedicine Prescribing Flexibilities for Controlled Medication
On May 9, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” [...]